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ABSTRACT Chemical denaturant sensitivity of the dimeric main protease from severe acute respiratory syndrome (SARS)
coronavirus to guanidinium chloride was examined in terms of ﬂuorescence spectroscopy, circular dichroism, analytical ultra-
centrifuge, and enzyme activity change. The dimeric enzyme dissociated at guanidinium chloride concentration of ,0.4 M, at
which the enzymatic activity loss showed close correlation with the subunit dissociation. Further increase in guanidinium chlo-
ride induced a reversible biphasic unfolding of the enzyme. The unfolding of the C-terminal domain-truncated enzyme, on the
other hand, followed a monophasic unfolding curve. Different mutants of the full-length protease (W31 and W207/W218), with
tryptophanyl residue(s) mutated to phenylalanine at the C-terminal or N-terminal domain, respectively, were constructed. Un-
folding curves of these mutants were monophasic but corresponded to the ﬁrst and second phases of the protease, re-
spectively. The unfolding intermediate of the protease thus represented a folded C-terminal domain but an unfolded N-terminal
domain, which is enzymatically inactive due to loss of regulatory properties. The various enzyme forms were characterized
in terms of hydrophobicity and size-and-shape distributions. We provide direct evidence for the functional role of C-terminal
domain in stabilization of the catalytic N-terminal domain of SARS coronavirus main protease.
INTRODUCTION
Severe acute respiratory syndrome (SARS) was one of the
most serious epidemic diseases in 2003 and is still a threat to
the public health worldwide (1). A speciﬁc SARS corona-
virus (CoV) was identiﬁed to be the contagious agent. Mat-
uration of the SARS-CoV involves proteolytic processing of
the virus polyproteins by the chymotrypsin-like main pro-
tease (3CLpro) and a papain-like protease (PLpro). SARS-
CoV might invade cells by a protease-mediated endosomal
pathway (2). Any knowledge about the structural stability of
viral protease can be very rewarding for the development of
antivirus drugs (3–6).
The 3CLpro from SARS-CoV was the ﬁrst protein of this
virus to have its three-dimensional structure solved (7,8). As
had previously been shown for the 3CLpro of transmissible
gastroenteritis (corona)virus (9), the SARS-CoV enzyme
also exists as a dimer in solution and in crystals, with each
subunit containing three structural domains (Fig. 1). The
catalytic dyad His41-Cys145 is located between the interfaces
of domains I (residues 8–99) and domain II (residues 100–
183), which constitute the chymotrypsin-like folding scaf-
fold. This catalytic N-terminal domain is connected by a long
loop (residues 184–199) to the helical domain III (residues
200–306). The functional role of the extra C-terminal do-
main III is less clear. Numerous experimental evidence
shows the importance of N- and C-terminal residues in the
dimerization (4,10–12). Structural studies indicate the close
proximity of C-terminus and N-ﬁnger (N-terminal residues
1–7) (9) from subunit A to the active site of subunit B that led
to the development of a novel autocleavage mechanism that
can explain the dimeric nature of the mature enzyme (13).
Here we demonstrate that the SARS main protease
provides us a very useful model for the folding studies of
multisubunit, multidomain proteins. Novel folding interme-
diates were identiﬁed, which allow us to delineate unequiv-
ocally the functional role of domain III.
MATERIALS AND METHODS
Construction of 3CLpro expression vectors
The genes of the full-length 3CLpro and C-terminal truncated 3CLI1II of the
SARS-CoV main protease were ampliﬁed by polymerase chain reaction
(PCR) with appropriate primers. The forward primers for full length was
59-GGTGGTCATATGAGTGGTTTTAGG-39, and the reverse primer was
59-AACTCGAGGGTAACACCAGAG-39. After digestion with BglII and
XhoI, the PCR product was divided into two fragments, 168-bp and 747-bp.
The 168-bp fragment was then digested with NdeI. Finally, the 168-bp NdeI-
BglII and 747-bp BglII-XhoI fragments were coligated to the NdeI and XhoI
sites of the vector pET-29a(1) (Novagen, Madison, WI ). The 3CLI1II was
subsequently ampliﬁed by PCR, using the forward primer of 59-TGAAG-
ATCTGCTCATTCGCAA-39, and reverse primer of 59-AACTCGACTAT-
GGTTGTGTCTG-39. After digestion with BglII and XhoI, the PCR products
were inserted into the BglII and XhoI sites of the pET-SARS main protease.
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Site-directed mutagenesis (14) was used to construct pET-H41A, pET-S65A,
pET-N84A, pET-C145A, pET-Y161A, and pET-H163A vectors. The for-
ward primers for H41A, S65A, N84A, C145A, Y161A, and H163A were
59-CTGTCCAAGAGCGGTCATTTGCAC-39, 59-CAAATCCAACCAT-
GCGTTTCTTGTTC-39, 59-CATTCTATGCAAGCGTGTCTGCTTAG-39,
59-CTTAATGGATCAGCGGGTAGTGTTG-39, 59-GTCTTTCTGCGCG-
ATGCATCATATG-39, and 59-CTGCTATATGGCGCATATGGAGC-39,
respectively; and the reverse primers were 59-GTGCAAATGACCGC-
TCTTGGACAG-39, 59-GAACAAGAAACGCATGGTTGGATTTG-39,
59-CTAAGCAGACACGCTTGCATAGAATG-39, 59-CAACACTACCCG-
CTGATCCATTAAG-39, 59-CATATGATGCATCGCGCAGAAAGAC-39,
and 59-GCTCCATATGCGCCATATAGCAG-39, respectively. The pET-3CL
expression vectors were used as templates and the primers as described
above were used to mutate the His41, Ser65, Asn84, Cys145, Tyr161, and
His163 codons to alanine codon by PCR. The mutational sites are shown
underlined and in bold.
For the tryptophan mutants of 3CLpro, the forward primers for W31F,
W207F, and W218F were 59-CTCTTAATGGATTGTTCTTGGATGACA-
CAGT-39, 59-CCATAACATTAAATGTTTTGGCATTCCTGTATGCT-
GC-39, and 59-CAATGGTGATAGGTTCTTTCTTAATAGATTCACC-39,
respectively. The reverse primers were 59-ACTGTGTCATCCAAGAA-
CAATCCATTAAGAG-39, 59-GCAGCATACAGGAATGCCAAAACA-
TTTAATGTTATGG-39, and 59-GGTGAATCTATTAAAGAAGAACC-
TATCACCATTG-39, respectively. For W207F/W218F (W31) double
mutant, W207F was used as the template.
All nucleotide sequences were conﬁrmed by autosequencing analysis. A
sequence comparison bearing the mutation positions at the active site region
is shown in supplemental Fig. 1S (Supplementary Material). The wild-type
(WT) enzyme and all mutants were successfully expressed and puriﬁed to
apparent homogeneity by protocols described previously (11). Typical CD
spectra of the recombinant 3CLpro are shown in Supplementary Material
(Fig. 2S).
Enzyme activity assay of SARS-CoV main
protease using ﬂuorogenic substrate
The enzyme kinetic measurements were performed in 30 mM Tris-Cl buffer
(pH 7.7) or phosphate-buffered saline (pH 7.6) at 30C. Enhanced ﬂuo-
rescence due to cleavage of the internal quenched ﬂuorogenic substrate
peptide (ortho-aminobenzoic acid-TSAVLQSGFRK-2,4-dinitrophenyl am-
ide) was monitored at 420 nm with excitation at 362 nm using a Perkin-
Elmer LS-50B luminescence spectrometer.
The kinetic parameters were obtained by assaying the enzyme activity at
various peptide substrate concentrations around its Michaelis constant (Km)
(11). The initial velocities (vo) were measured and ﬁtted to the Michaelis-
Menten equation (Eq. 1):
vo ¼ kcat½Et½S
Km1 ½S ; (1)
where kcat is the catalytic constant; [E]t, is the enzyme concentration, and [S],
is the substrate concentration.
Reversible unfolding/refolding of the enzyme
in GdnCl
WT (3CLpro) or domain III-deleted (3CLI1II) SARS-CoVmain proteasewas
unfoldedwith different concentrations ofGdnCl in Tris-Cl buffer (30mM,pH
7.7) at 30C for 10 min. The unfolding of the enzyme was monitored by
ﬂuorescence, CD, sedimentation velocity, and enzyme activity loss. The
unfolding was found to reach equilibrium in transient. A 10-min incubation,
both unfolding and refolding, was used in the experiments in this study.
Spectroﬂuorimetric analysis
Fluorescence spectra of the enzyme were monitored in a Perkin-Elmer LS-
50B luminescence spectrometer at 30C, and all spectra were corrected for
buffer absorption. The excitation wavelength was set at 280 nm (295 nm for
tryptophan mutants, W31 and W207/W218), and the ﬂuorescence emission
spectrum was scanned from 300 to 400 nm. The maximal peak of the
ﬂuorescence spectrum and the change in ﬂuorescence intensity were used in
monitoring the unfolding processes of the enzyme. Both the red shift and the
changes in ﬂuorescence intensity were analyzed together using the average
emission wavelength (AEW) (Ælæ) according to Eq. 2 (15):
Ælæ ¼
+
lN
i¼l1
ðFi3 liÞ
+
lN
i¼l1
Fi
; (2)
in which Fi is the ﬂuorescence intensity at the speciﬁc emission wavelength (li).
FIGURE 1 Structural features of SARS-CoVmain protease. (A) The three
structural domains of SARS-CoV main protease are shown in rainbow color
(Protein Data Bank code: 1Z1I). The catalytic dyad His41-Cys145 between
domains I and II are highlighted with red side chain. The important residues
Tyr161 and His163 in the substrate-binding pocket are shown in blue side
chain. The tryptophanyl residues Trp31, Trp207, and Trp218 are shown in
green side chain. Other two residues Ser65 and Asn84 located at surface are
also shown. (B) Surface model showing the unsymmetrical dimer associ-
ation mode. N-terminal domain and C-terminal domain of subunit A are in
blue and light blue, respectively. Generate with Pymol (37).
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Exposure of the enzyme hydrophobic areas was examined by mixing the
enzyme solution with 1-anilino-8-naphthalene sulfonic acid (ANS) and the
ﬂuorescence emission spectrum between 400 and 600 nm was recorded with
excitation at 395 nm.
Circular dichroism analysis
CD spectra were measured at 30C with a Jasco J-810 spectropolarimeter
under constant N2 ﬂush. The enzyme solution was scanned from 300 to 190
nm. When the analysis was completed, the buffer was immediately scanned
to obtain the baseline. Unfolded enzyme solution was ﬁltered through a
0.22-mm ﬁlter (Whatman, UK) before analysis. Denaturing agent included
in the buffer was used to monitor the baseline for the unfolded enzyme.
Mean residue ellipticity [Q] was calculated according to Eq. 3:
½Q ¼ M3Q
1003 C3 l
; (3)
where l represents the light path length (dm); M, the average molecular
weight of amino acids; C, the concentration of protein (mg/ml); and Q, the
observed ellipticity.
Analytical ultracentrifugation
Sedimentation velocity was performed in a Beckman-Coulter XL-A analy-
tical ultracentrifuge with an An50Ti rotor at 20C and 42,000 rpm in 12-mm
double-sector Epon charcoal-ﬁlled centerpieces. The ultraviolet (UV) ab-
sorption of the cells at 280 nm was scanned in a continuous mode with time
interval of 8 min and a step size of 0.003 cm. The partial speciﬁc volume
of the enzyme, solvent density, and viscosity were calculated by the free
software SEDNTERP (http://www.jphilo.mailway.com/). All samples were
visually checked for clarity after ultracentrifugation to make sure that there
was no indication of precipitation due to unfolding of the protein. Multiple
scans at different time points were analyzed with the SEDFIT program
(16,17).
The size-and-shape distributions of the enzyme in the presence of GdnCl
were analyzed with a new feature of SEDFIT (17) that allowed full ex-
ploration of the protein conformational changes. The sedimentation velocity
data were ﬁtted using a two-dimensional distribution with respect to fric-
tional ratio c(s, f / fo) according to Lamm equation (17,18) (Eq. 4):
aðr; tÞ ¼
Z Z
cðs; f =foÞxðs;Dðs; f =foÞ; r; tÞdsdð f =foÞ; (4)
with a(r,t) denoting the observed optical signal at radius r and time t;
x(s,D,r,t), the solution of the Lamm equation; and D(s, f/fo), the dependence
of diffusion coefﬁcient (D) on sedimentation coefﬁcient (s) and frictional
ratio (f/fo), where
@x
@t
¼ 1
r
@
@r
rD
@x
@r
 sv2r2x
 
(5)
Dðs; f =foÞ ¼
ﬃﬃﬃ
2
p
18p
kTﬃﬃ
s
p 1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðh f =foÞ3
q
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 vr
v
r
; (6)
with v denoting angular velocity; k, Boltzmann constant; T, absolute tem-
perature; n, enzyme partial speciﬁc volume; h, buffer viscosity; and r, buffer
density.
All two-dimensional distributions were solved and normalized to a con-
ﬁdence level of p ¼ 0.95 by maximum entropy and a resolution N of 200
with sedimentation coefﬁcients between 0.1 and 20 S. The anhydrous fric-
tion ratio is from 1.0 to 2.0 or 3.5 at a resolution of 10.
Unfolding data analysis
Because unfolding/refolding is a reversible process (see Fig. 2), the un-
folding data were treated with the following thermodynamic models by
global ﬁtting of the data to Eq. 7 or Eq. 8:
The two-state unfolding model (Scheme I) was described by Eq. 7 (19):
N ! KNU U (Scheme I)
yobs ¼ yN1 yU  e

DGðH2OÞN/UmN/U ½GdnCl
RT
 
11 e

DGðH2OÞN/UmN/U ½GdnCl
RT
  : (7)
The three-state unfolding model (Scheme II) was described by Eq. 8 (20):
N ! KNI I ! KIU U (Scheme II)
FIGURE 2 Equilibrium unfolding/refolding of the SARS-CoV main
protease in GdnCl. The enzyme (5 mg/ml for 3CLpro and 15 mg/ml for
3CLI1II) in 30 mM Tris-Cl buffer (pH 7.7) was excited with 280 nm UV
light and the protein intrinsic ﬂuorescence emission spectra were monitored
at 30C. (A) 3CLpro; (B) 3CLI1II. Curves are: (a) native enzyme in Tris-Cl
buffer; (b) native enzyme in the same buffer containing 0.6 M GdnCl; (c)
unfolded enzyme in 6 M GdnCl-buffer; (d) refolded enzyme in 0.6 M
GdnCl-buffer. In curve d, the protein was unfolded in 6 M GdnCl-buffer for
10 min and then diluted 10-fold with the buffer. All samples were treated
with GdnCl-buffer or buffer-only simultaneously for the same duration. The
ﬁnal enzyme concentrations were the same for all spectra.
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where yobs is the observed biophysical signal; yN, yI, and yU are the calculated
signals of the native, intermediate, and unfolded states, respectively. [GdnCl]
is the GdnCl concentration, and DGN-I andDGI-U are the free energy changes
for the N4I and I4U processes, respectively; mN-I and mI-U are the sen-
sitivities of the respective unfolding process to denaturant concentration.
RESULTS
Active site region of SARS-CoV main protease
The original crystal structure of SARS-CoV main protease
revealed that the dimeric enzyme is half-sited at pH 6.0, in
which one of the protomer appears to be active and the other
inactive (7). In a recent article, Chen et al. (21) conﬁrmed
that the dimeric SARS-CoV main protease is asymmetric
and only one protomer is active at a time. They proposed a
novel association-activation-catalysis-dissociation mecha-
nism for the enzyme activity control. We checked whether
dissociation is the major reason for enzyme inactivation. The
following residues were selected for analysis: His41 and
Cys145, the catalytic dyad; His163, the substrate-binding resi-
due; Tyr161, residue for holding His163 in place. Some sur-
face residues at domain I, Ser65 and Asn84, were also selected
as control. In the Ramachandran plot (22), Asn84 is in the
disallowed region of the unbound 3CLpro but in a gener-
ously allowed region of a 3CLpro-azapeptide inhibitor com-
plex (23). Table 1 summarizes the kinetic parameters of these
mutants. Mutation at catalytic dyad residues (H41A and
C145A) abolishes almost the complete biological function
while the enzyme exists exclusively as dimer. Assuming that
the rate-limiting step of the hydrolytic activity of 3CLpro,
like chymotrypsin, is at the covalent acylation-deacylation
step, then the Km value for the substrate reﬂects an apparent
binding afﬁnity for the enzyme-substrate complex. However,
mutation at S1 site (H163A) of the substrate-binding pocket
did not change the substrate binding appreciably as antic-
ipated. The major effect was on the kcat value. H163A pos-
sessed ;0.1% of enzyme activity compared with WT. In
contrast, the catalytic dyad mutants, H41A and C145A, had
only 106 relative activity left.
An interesting ﬁnding was the Y161A mutant, which has
only 7 3 105 relative enzymatic activity left. Y161A dis-
sociated to an unstable monomer that is prone to polymerize
(Supplementary Material, Fig. 3S).
Reversible unfolding of SARS-CoV main protease
in GdnCl
SARS-CoV 3CLpro was denatured at high temperature. The
thermal denaturation was irreversible. White coagulations
occurred in the cuvettes when the enzyme at 0.3–0.4 mg/ml
in phosphate-buffered saline (pH 7.6) was heated to 60C for
30 min (data not shown). This result was also observed in
other studies (24,25). Thermal unfolding is thus not suitable
for further analysis of the unfolding process of 3CLpro.
The ﬂuorescence emission spectrum of the native enzyme
shows a maximum at 328 nm (Fig. 2 A, curve a). The enzyme
was very sensitive to GdnCl. In the presence of 6Mof GdnCl,
the enzyme was completely unfolded in 10 min and the
maximum emission ﬂuorescence was shifted to 358 nm (Fig.
2 A, curve c). The unfolding was found to be completely
reversible. A simple 10-fold dilution instantaneously induced
refolding of the enzyme to a yield of 92–95% as judged by the
ﬂuorescence spectrum recovery (Fig. 2 A, curve d).
Similar results were obtained for the C-terminal domain-
III-truncated enzyme (3CLI1II) in which only one buried
tryptophanyl residue remained and thus very little ﬂuores-
cence was detected in the folded state (Fig. 2 B, curve a). The
GdnCl-induced unfolding is thus very suitable for confor-
mational stability studies of the enzyme.
Unfolding curves of SARS-CoV main protease in
various concentrations of GdnCl
Unfolding of the enzyme in different concentrations of
GdnCl is shown in Fig. 3. When the integrated ﬂuorescence
area was calculated at various GdnCl concentrations, a
yobs ¼ yN1 yI  e

DGðH2OÞN/ImN/I ½GdnCl
RT
 
1 yU  e

DGðH2OÞN/ImN/I ½GdnCl
RT
 
 e
DGðH2OÞI/UmI/U ½GdnCl
RT
 
11 e

DGðH2OÞN/ImN/I ½GdnCl
RT
 
1 e

DGðH2OÞN/ImN/I ½GdnCl
RT
 
 e
DGðH2OÞI/UmI/U ½GdnCl
RT
  ; (8)
TABLE 1 Kinetic parameters of the SARS-CoV main
protease mutants
Protease
Quaternary
structure
Km
(mM)
kcat
(103 s1)
kcat/Km
(mM1 s1)
Experiment Iz
3CLpro Dimer 10.5 6 3.1 85.5 6 7.1 8.1 6 2.5
H41A* Dimer – 0.0002 –
C145A* Dimer – 0.0002 –
H163A Dimer 17.5 6 4.2 0.14 6 0.01 0.008 6 0.002
Y161A* Monomer/
polymer
– 0.006 –
S65A Dimer 32.0 6 9.9 96.2 6 14.3 3.0 6 1.0
N84A Dimer 9.9 6 2.3 64.1 6 11.5 6.5 6 1.9
3CLI1II Monomer ND
y NDy NDy
Experiment II§
3CLpro Dimer 14.5 6 4.5 5.2 6 0.7 0.4 6 0.1
W31 Dimer 18.7 6 7.8 5.9 6 1.1 0.3 6 0.1
W207/W218 Dimer 14.5 6 4.3 11.0 6 1.3 0.8 6 0.3
*The enzyme activities for these mutants were too small to get reliable
kinetic parameters, only relative activity was reported.
yNot detectable.
zDetermined in phosphate-buffered saline (pH 7.6).
§Determined in 30 mM Tris-Cl buffer (pH 7.7).
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monophasic unfolding process seems sufﬁcient for describ-
ing the data (Fig. 3 C). However, there is a strong denaturant-
dependent pretransition slope, which might indicate exposure
of hydrophobic areas (26). Similar results were obtained with
CD spectra (Fig. 3 D). More interesting results are shown in
Fig. 3 B, which shows clearly a biphasic red shifting of the
ﬂuorescence emission peak from 328 to 358 nm upon ad-
dition of GdnCl. The average emission wavelength (Fig. 3 A)
that registered changes in both ﬂuorescence wavelength and
ﬂuorescence intensity was used to calculate the thermody-
namic parameters of the unfolding/refolding process (Table 2).
The folded enzyme started to unfold beyond;0.4 MGdnCl
and reached an unfolding intermediate with [GdnCl]0.5,N-I at
1.1M.The secondunfoldingphase started at;3Mdenaturant
with [GdnCl]0.5,I-U ¼ 4.0 M, corresponding to free energy
change (DG) of 1.226 0.16 kcal/mol, and 10.886 0.27 kcal/
mol, respectively, for the N4 I and I4 U processes.
Quaternary structural changes of SARS-CoV
main protease in the presence of GdnCl
The above results indicate clearly a biphasic unfolding curve
for the dimeric enzyme. It is ultimately important to differ-
entiate between dissociation versus unfolding under GdnCl.
Analytical ultracentrifugation was used to examine this point.
Fig. 4 A shows a typical sedimentation velocity proﬁle for the
enzyme in the presence of 0.4MGdnCl. As shown in Fig. 4, B
and C, the enzyme already dissociated to monomers at 0.4 M
GdnCl. The major species of 4.6 6 0.2 S corresponds to a
dimer in the absence of GdnCl (Fig. 4 C), whereas in 0.4 M
GdnCl the major peak corresponds to a monomer with a value
of 2.9 6 0.2 S. An equivalent continuous distribution C(s,M)
plot (not shown) indicated the dissociation of dimeric 3CLpro
with molecular mass of 61 6 17 kDa in buffer to a monomer
with molecular mass of 33 6 6 kDa in 0.4 M GdnCl. The
biphasic-unfolding phenomenon is thus not a dissociation-
unfolding process. Fig. 3, A and B, then represents a folding/
unfolding process of the dissociated monomer.
Correlation of quaternary structural changes of
SARS-CoV main protease with enzymatic activity
We then examined the enzymatic activity change upon
GdnCl unfolding. The results shown in Fig. 5 indicate the
close correlation of enzymatic activity loss with dimer disso-
ciation. It should be noted that the protein concentrations
were different in these experiments. The amount of enzyme
used in activity assay (5 mg/ml) is much smaller than that
used in AUC experiment (0.5–0.85 mg/ml). However, this
still suggests that dissociation induces enzyme inactivation.
Possibility of unfolding intermediate as a molten
globule state
After dissociation, the conformational changes of 3CLpro
were clearly demonstrated by the increase in frictional ratio
of the enzyme upon addition of GdnCl (Fig. 5). Analytical
ultracentrifugation provides very detailed conformational
information about the enzyme structural changes. Signiﬁcant
unfolded intermediate (15%) with frictional ratio of 2.67 was
detected at 2 M GdnCl. This unfolded intermediate form was
FIGURE 3 Unfolding curves of the full-length (3CLpro) SARS-CoVmain
protease in different concentrations of GdnCl. The enzyme, 3CLpro, 5 mg/ml
(A–C) and 0.35 mg/ml (D) in 30 mMTris-Cl (pH 7.7) wasmixedwith various
concentrations of GdnCl. The ﬂuorescence (A–C) or CD spectrum (D) was
recorded after 10 min incubation at 30C. (A) Average ﬂuorescence emission
wavelength (AEW) (Eq. 2). (B) Fluorescence emission wavelength shift. (C)
Integrated ﬂuorescence area. (D) Circular dichroism changes at 222 nm versus
GdnCl concentration. Solid symbols are experimental data and the smooth
curves are computer-generated best-ﬁtted lines according to a three-state
unfolding model (A and B) (Eq. 8) or a two-state unfolding model (C and D)
(Eq. 7). The ﬁtting residuals are also shown under each panel (open circles).
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not detected at 0.4 M or 4 M GdnCl, in which the enzyme
existed exclusively as folded monomers or unfolded mon-
omers, respectively.
The above observed unfolding intermediate may represent
a molten globule state with exposure of the interior hydro-
phobic area, which will have pronounced binding ability to
ANS and have a higher propensity to aggregate (27). How-
ever, no precipitation was observed for 3CLpro at any of the
GdnCl concentrations. Neither was polymerization detected
by AUC. ANS binding ability of the GdnCl-unfolded en-
zyme remained unchanged (SupplementaryMaterial, Fig. 4S).
This probably excludes a gross conformational change of the
enzyme and the major intermediate form detected at 1–4 M
GdnCl may not represent a partially unfolded molten globule
state. The remaining possibility is then differential domain
stability. The unfolding of 3CLI1II was then examined.
Unfolding curves of the C-terminal domain-truncated
SARS-CoV main protease (3CLI1II)
In the presence of GdnCl, 3CLI1II follows the simple
monophasic-unfolding curve (Fig. 6), which is also com-
pletely reversible (Fig. 2 B). Compared with the unfolding
curve of the full-length 3CLpro, it is very likely that the
biphasic unfolding of 3CLpro represents differential confor-
mational stability of domain (I 1 II) and domain III.
This helps us to differentiate domain stability of 3CLpro
and assign the functional role of domain III. However, it is
still difﬁcult to assign the corresponding domain to the
biphasic unfolding. To provide a structural basis for the
biphasic unfolding curves shown in Fig. 3, A and B, we
constructed two mutants of 3CLpro, each with tryptophanyl
residue(s) mutated at different domain and the ﬂuorescence
TABLE 2 Stability parameters of SARS-CoV full-length and C-terminal truncated main proteases
Protease DGN-I (kcal mol
1) mN-I (kcal mol
1 M1) [GdnCl]0.5,N-I (M) DGI-U (kcal mol
1) mI-U (kcal mol
1 M1) [GdnCl]0.5,I-U (M)
3CLpro* 1.22 6 0.16 1.15 6 0.11 1.1 6 0.2 10.88 6 0.27 2.70 6 0.07 4.0 6 0.1
W31y 1.39 6 0.46 0.91 6 0.22 1.5 6 0.6 – – –
W207/W218y – – – 10.25 6 0.47 2.49 6 0.12 4.1 6 0.3
3CLI1II
y 7.27 6 0.35 4.94 6 0.23 1.5 6 0.1
*The unfolding data were ﬁtted to a three-state unfolding model according to Eq. 8.
yThe unfolding data were ﬁtted to a two-state unfolding model according to Eq. 7.
FIGURE 4 Quaternary structural changes of SARS-CoV main protease in
GdnCl. Continuous sedimentation analysis of the SARS-CoV main protease
in the presence and absence of GdnCl. (A) Sedimentation of the enzyme in
30 mM Tris-Cl (pH 7.7) containing 0.4 M GdnCl. The sedimentation
velocity data were analyzed with SEDFIT (17). The ﬁtting residuals are
shown under the panel. (B) C(s, f/fo) distribution of the enzyme in 0.4 M
GdnCl. (C) C(s, f/fo) distribution of the enzyme in the absence of GdnCl.
FIGURE 5 GdnCl-induced dissociation and unfolding of SARS-CoV
main protease. (Open circles) Remaining enzyme activity; (open triangles)
remaining dimer percentage. Unfolding of the enzyme was demonstrated
by the contour of continuous sedimentation coefﬁcient and frictional ratio
C(s, f/fo) with the most concentrated region shown in red. The x axis of
these contours has no physical meaning.
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of these mutants now reports the structural changes of in-
dividual domain.
Unfolding curves of the tryptophanyl
residue(s)-mutated SARS-CoV main protease
3CLpro has a total of three tryptophanyl residues (Trp31 at
domain I, Trp207 and Trp218 at domain III, domain II has no
Trp) (Fig. 1 A). W31, a double mutant with both Trp207 and
Trp218 of domain III mutated to phenylalanine and only one
tryptophanyl residue (Trp31) remained. When excited with
295 nm UV light, the protein intrinsic emission ﬂuorescence
came from the tryptophanyl residue only. Thus W31 will
only report the structural information of the N-terminal
domain. Similarly, W207/W218, a single W31F mutant, will
register the conformational change of the C-terminal domain.
Mutation at these tryptophanyl residues to phenylalanine
did not change the kinetic properties of the enzyme. The kcat
and Km values of W31 or W207/W218 were in the same
order as in WT. The AUC data indicated that these Trp
mutants still existed as dimer in solution (Table 1). When
W31 and W207/W218 were unfolded in GdnCl, the ﬂuore-
scence signal showed monophasic in both cases but distinct
unfolding curves of these mutants were obtained (Fig. 7). It
is clear that the N-terminal domain of 3CLpro (W31) is
unfolded ([GdnCl]0.5 ; 1 M) before the C-terminal domain
(W207/W218) ([GdnCl]0.5 ; 4 M). The unfolding param-
eters of 3CLI1II thus represented the ﬁrst phase of the
3CLpro (Table 2).
FIGURE 6 Unfolding curves of the C-terminal domain-truncated mutant
(3CLI1II) SARS-CoV main protease in different concentrations of GdnCl.
The 3CLI1II enzyme (13.3 mg/ml in panels A–C, and 0.18 mg/ml in panelD)
in 30 mM Tris-Cl (pH 7.7) was mixed with various concentrations of GdnCl.
The ﬂuorescence (A–C) or CD spectrum (D) was recorded after 10 min
incubation at 30C. (A) Average ﬂuorescence emission wavelength (AEW)
(Eq. 2). (B) Fluorescence emission wavelength shift. (C) Integrated ﬂuo-
rescence area. (D) Circular dichroism changes at 222 nm versus GdnCl
concentration. Solid symbols are experimental data and the smooth curves are
computer-generated best-ﬁtted lines according to a two-state unfoldingmodel
(Eq. 7). The ﬁtting residuals are shown under each panel (open circles).
FIGURE 7 Unfolding curves of the tryptophanyl residue(s)-mutated
SARS-CoV main protease in different concentrations of GdnCl. The mutant
3CLpro, W31 (40 mg/ml) (A) or W207/W218 (18 mg/ml) (B), in 30 mM
Tris-Cl (pH 7.7) was mixed with various concentrations of GdnCl. The
enzyme solution was excited at 295 nm, and the emission ﬂuorescence was
recorded at 30C. Average ﬂuorescence emission wavelength (AEW) (Eq. 2)
of each mutant was used to present the unfolding data. (A) W31 (or more
precisely W207F/W218F) represents the structural change of N-terminal
domain. (B) W207/W218 (or more precisely W31F) represents the structural
change of C-terminal domain. Solid symbols are experimental data and the
smooth curves are computer-generated best-ﬁtted lines according to a two-
state unfolding model (Eq. 7). The ﬁtting residuals are shown under each
panel (open circles).
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DISCUSSION
Some of the active site residues of SARS-CoV and related
coronavirus main proteases have been explored previously.
Thus Cys145 and His163 have been mutated in 3CLpro of
transmissible gastroenteritis (corona) virus (9); His41, Cys145,
Tyr161 in feline infectious peritonitis virus (28); and Cys145
in SARS-CoV (10,13,29). Table 1 summarizes the results
obtained in this study. As expected, the almost complete loss
of enzymatic activity of H41A and C145A conﬁrmed the
catalytic roles of the catalytic dyad (29,30). Similar obser-
vations were made for His163 and Tyr161. Both of these
residues are involved in substrate binding. The main function
of Tyr161 is to hold His163 in place. Mutation of His163 led to
a relatively small increase in Km but a large drop in kcat
(Table 1). This could result from the enzyme activity assays
being performed at pH 7.6, where one protomer of the
dimeric enzyme adopts a different conformation from that in
acidic environment (7). It has been postulated by Tan et al.
(30) and also by Yang et al. (7) that at low pH, protonation of
His163 induces a series of conformational changes that lead
to the collapse of the oxyanion hole and blocks the S1 pocket
entry. This would be in full agreement with the observation
of a very large decrease in kcat as shown in Table 1. An
intriguing question will then be testing the pH-activity
proﬁle of H163A mutant to conﬁrm that His163 is responsible
for the lower activity of 3CLpro at pH 6.0 as predicted by
molecular dynamic simulation (30).
The contribution of this study includes our presentation of a
clear-cut dissociation-denaturation proﬁle as well as a differ-
ential domain unfolding process. Protein folding constitutes
one of the most challenging problems in the life science area
(31–35). The SARS-CoV main protease has a unique
structure with distinct structural domains. Each subunit of
the protein has 13 strands and 11 helices, distributed in
different structural domains (7). A multiphasic unfolding
process may be anticipated. From the present analyses, the
differential stability of different structural domains of the
enzyme was deduced in terms of their free energy changes
during transformation from the folded state to the unfolded
state with an intermediate state involvement of folded domain
III but unfolded domain (I1II) by the following reasoning.
Bacha et al. (24) had demonstrated the intrinsic instability
of the C-terminal domain III by differential scanning
calorimetry albeit this technique seemingly does not provide
enough resolution to detect the unfolding intermediate. We
observed a clear biphasic unfolding curve for the 3CLpro by
the protein intrinsic ﬂuorescence. The intermediate form was
assigned to a folded C-terminal domain but an unfolded
N-terminal domain on the basis of the following observa-
tions: a), Our unfolding data of 3CLpro clearly demonstrate
the biphasic-unfolding process and our data of 3CLI1II
(N-terminal domain) suggest attributing the ﬁrst and second
phases of the 3CLpro to the N- and C-terminal domains,
respectively (Table 2). b), Unequivocal assignment of the
biphasic unfolding curve to differential domain stability
came from results shown in Fig. 7. The W31 and W207/
W218 are full-length 3CLpro. The unfolding curves shown
in Fig. 7 should be biphasic. However, because the protein
was excited with 295 nm UV light, one of the domain
unfoldings is invisible and the unfolding curve only regis-
tered the structural changes of the tryptophan-containing
domain. W31 and W207/W218 thus report conformational
changes of the N-terminal and C-terminal domains, respec-
tively. It is then clear that the N-terminal domain is labile
than the C-terminal domain. The stabilization of the catalytic
N-terminal domain by the C-terminal domain III is thus
conﬁrmed. The intrinsic conformational stability of domain
(I1II) without domain III has a much higher free energy
(7.27 kcal mol1) than full-length 3CLpro (1.22 kcal mol1)
(Table 2). The signiﬁcant larger mGdnCl value of 3CLI1II
(4.94 kcal mol1 M1) than full-length 3CLpro (1.15 kcal
mol1 M1) clearly indicates the pronounced increase of
surface area exposure on denaturation of 3CLI1II (26). This
actually deﬁnes the functional role of domain III in SARS-
CoV main protease.
After dissociation, the distribution of three structural forms
of 3CLpro in various GdnCl concentrations is very clear. It
includes a folded monomer, an intermediate with folded
domain III but unfolded domain (I1II), and a completely
unfolded form. The enzyme starts to dissociate at very early
stage, at GdnCl concentration of ,0.1 M. The dissociated
monomer then starts to unfold at ,0.4 M and reaches the
ﬁrst plateau at 2–3 M. The second unfolding then starts,
which reaches another plateau at 4.5 MGdnCl. The complete
dissociation and differential unfolding of the structural do-
mains are summarized in Fig. 8. This schematic presentation
FIGURE 8 A schematicmodel for the dissociation and unfolding of SARS-CoVmain protease inGdnCl. The stepwise dissociation and unfolding of the dimeric
3CLpro are shown schematically with N-terminal domain in red and C-terminal domain in blue. Unfolding portions of the polypeptide are shown in red thread.
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only lists the major enzyme species of the complex folding
process. The sharp unfolding curves for 3CLI1II (Fig. 6) and
the completely reversible of the unfolding process (Fig. 2 B)
consistent with that 3CLI1II without domain III can fold
independently into an intact chymotrypsin-like fold. Domain
III thus must have extra functional role.
Shi and Song (36) have observed a nanochannel between
domain III and the active center and proposed a regulatory
effect of the extra domain III in relaying the catalytic ma-
chinery. Chen et al. (21) suggest that the enzyme follows an
association-activation-catalysis-dissociation catalytic cycle.
This will provide further insight into the functional role of
domain III in the dimerization and involvement in the en-
zyme activity regulation beyond simple stabilization of the
catalytic N-terminal domain.
In summary, both 3CLI1II and 3CLpro show a completely
reversible unfolding/refolding process in GdnCl. We dem-
onstrate here a clear-cut case of the differential stability of
quaternary and domain structures. The unfolding studies of
SARS-CoV main protease may shed light on the inherent
structural stability of this important viral enzyme.
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